Inside Story - India: Human lives vs pharma profits

Al Jazeera English 2012-08-29

Views 109

India has decided to end the monopoly of pharmaceutical giant Bayer, by overturning its patent of anti-cancer drug Nexavar. Guests: Yusuf Hamied; James Love; Kevin Craig
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Stocks in news: Sun Pharma, Cipla, Hindalco
play
03:25

Stocks in news: Sun Pharma, Cipla, Hindalco
Cipla to replace Sun Pharma in Sensex
play
01:53

Cipla to replace Sun Pharma in Sensex
Sensex Up By 145 Points, Sun Pharma, Cipla, Tata Motors Gain
play
02:17

Sensex Up By 145 Points, Sun Pharma, Cipla, Tata Motors Gain
Buy Cipla, Sun Pharma, Sell Tata Steel : Ashwani Gujral
play
01:11

Buy Cipla, Sun Pharma, Sell Tata Steel : Ashwani Gujral
Hot stocks: Cipla, Sun Pharma, Tata Steel, Bajaj Auto, BoB
play
01:18

Hot stocks: Cipla, Sun Pharma, Tata Steel, Bajaj Auto, BoB
We are still not taking buying call on Lupin, Cipla & Sun Pharma, says market guru SP Tulsian
play
08:34

We are still not taking buying call on Lupin, Cipla & Sun Pharma, says market guru SP Tulsian
Cipla Acquires South Africa's Actor Pharma
play
01:40

Cipla Acquires South Africa's Actor Pharma
Sun Pharma posts loss, Cipla gains from exports
play
01:07

Sun Pharma posts loss, Cipla gains from exports
Cipla - Indian pharma companies have better prospects overseas
play
08:27

Cipla - Indian pharma companies have better prospects overseas
Stocks In Focus | Hero Moto, M&M, Cipla, Gland Pharma, Olectra & More | BQ Prime
play
13:51

Stocks In Focus | Hero Moto, M&M, Cipla, Gland Pharma, Olectra & More | BQ Prime
The Best Pharma Franchise Company in India | Pharma Drugs & Chemicals
play
01:25

The Best Pharma Franchise Company in India | Pharma Drugs & Chemicals
Top PCD Pharma Franchise Business In India | Adegen Pharma
play
02:34

Top PCD Pharma Franchise Business In India | Adegen Pharma